open access
Vol 93, No 2 (2022)
Review paper
Published online: 2022-01-12
Get Citation
Safety and efficiency of COVID-19 vaccination during pregnancy and breastfeeding
Ewa Blaszczyk1
Affiliations- Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland, Poland
open access
Vol 93, No 2 (2022)
REVIEW PAPERS Obstetrics
Published online: 2022-01-12
Abstract
Despite the development of effective and safe vaccines, the contributions of pregnant women in clinical trials of vaccines have been excluded. Similarly, vaccine trials did not include breastfeeding women. This article is an overview of studies on immunization during pregnancy and breast-feeding. The manuscript is intended to collect the current data on the effectiveness and safety of COVID-19 vaccines in order to facilitate medical decision.
Abstract
Despite the development of effective and safe vaccines, the contributions of pregnant women in clinical trials of vaccines have been excluded. Similarly, vaccine trials did not include breastfeeding women. This article is an overview of studies on immunization during pregnancy and breast-feeding. The manuscript is intended to collect the current data on the effectiveness and safety of COVID-19 vaccines in order to facilitate medical decision.
Get Citation
About this articleTitle
Safety and efficiency of COVID-19 vaccination during pregnancy and breastfeeding
Journal
Issue
Article type
Review paper
Pages
168-172
Published online
2022-01-12
Page views
3616
Article views/downloads
866
DOI
10.5603/GP.a2021.0241
Pubmed
Bibliographic record
Ginekol Pol 2022;93(2):168-172.
Authors
Ewa Blaszczyk
References (28)- COVID Live Update: 180,330,762 Cases and 3,906,246 Deaths from the Coronavirus - Worldometer. https://www.worldometers.info/coronavirus/.
- Wang J, Peng Y, Xu H, et al. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech. 2020; 21(6): 225.
- Mullard A. Flooded by the torrent: the COVID-19 drug pipeline. Lancet. 2020; 395(10232): 1245–1246.
- COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care | ACOG. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care?utm_source=redirect&utm_medium=web&utm_campaign=int.
- Thomas SJ, Moreira ED, Kitchin N, et al. C4591001 Clinical Trial Group, C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020; 383(27): 2603–2615.
- Martins I, Louwen F, Ayres-de-Campos D, et al. EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women. Eur J Obstet Gynecol Reprod Biol. 2021; 262: 256–258.
- Abu Raya B, Edwards KM, Scheifele DW, et al. Pertussis and influenza immunisation during pregnancy: a landscape review. Lancet Infect Dis. 2017; 17(7): e209–e222.
- Hanson LA, Korotkova M, Lundin S, et al. The transfer of immunity from mother to child. Ann N Y Acad Sci. 2003; 987: 199–206.
- Van de Perre P. Transfer of antibody via mother's milk. Vaccine. 2003; 21(24): 3374–3376.
- Certain Medical Conditions and Risk for Severe COVID-19 Illness | CDC. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.
- Zdanowski W, Waśniewski T. Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results. Vaccines (Basel). 2021; 9(6).
- Gray KJ, Bordt EA, Atyeo C, et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. medRxiv. 2021; 225(3): 303.e1–303.e17.
- Prabhu M, Murphy EA, Sukhu AC, et al. Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood. Obstet Gynecol. 2021; 138(2): 278–280.
- Palmeira P, Quinello C, Silveira-Lessa AL, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012; 2012: 985646.
- Vilajeliu A, Goncé A, López M, et al. PERTU Working Group. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn. Vaccine. 2015; 33(8): 1056–1062.
- Vaccine Information and Safety Studies | Vaccine Safety | CDC. https://www.cdc.gov/vaccinesafety/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccinesafety%2Findex.htm.
- Dreier JW, Andersen AMN, Berg-Beckhoff G. Systematic review and meta-analyses: fever in pregnancy and health impacts in the offspring. Pediatrics. 2014; 133(3): e674–e688.
- Shimabukuro TT, Kim SY, Myers TR, et al. CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021; 384(24): 2273–2282.
- Perl SH, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women. JAMA. 2021; 325(19): 2013–2014.
- Kelly JC, Carter EB, Raghuraman N, et al. Anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination. Am J Obstet Gynecol. 2021; 225(1): 101–103.
- Schwartz A, Nir O, Toussia-Cohen S, et al. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine. Am J Obstet Gynecol. 2021; 225(5): 577–579.
- Bertrand K, Honerkamp-Smith G, Chambers CD. Maternal and Child Outcomes Reported by Breastfeeding Women Following Messenger RNA COVID-19 Vaccination. Breastfeed Med. 2021; 16(9): 697–701.
- Schlaudecker EP, Steinhoff MC, Omer SB, et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLoS One. 2013; 8(8): e70867.
- Demers-Mathieu V, Huston RK, Markell AM, et al. Impact of pertussis-specific IgA, IgM, and IgG antibodies in mother's own breast milk and donor breast milk during preterm infant digestion. Pediatr Res. 2021; 89(5): 1136–1143.
- Fowlkes A, Gaglani M, Groover K, et al. HEROES-RECOVER Cohorts. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(34): 1167–1169.
- Torjesen I. Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ. 2021; 375: n2943.
- Delahoy MJ, Whitaker M, O'Halloran A, et al. COVID-NET Surveillance Team. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(38): 1347–1354.
- Woodworth KR, Olsen EO, Neelam V, et al. CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT). Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(44): 1635–1640.
